Care rated ‘overweight’ by Aljazira Capital; target price at SAR 74.4

24/06/2015 Argaam

Aljazira Capital, the investment arm of Aljazira Bank, maintained its “overweight” recommendation for National Medical Care Company (Care) and set a target price of SAR 74.4 per share.

 

Care’s profit is seen to grow 21.3 percent to SAR 113.5 million this year on higher revenue expected after the company completes its Riyadh hospital expansion, Aljazira added.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.